Modernizing Safety Operations with AI: How Bristol Myers Squibb Achieved 25% Efficiency Gains in PV Case Intake and Processing
Bristol Myers Squibb's Patient Safety team wanted to modernize pharmacovigilance operations to make case intake and processing more efficient. BMS partnered with ArisGlobal (technology, via its LifeSphere platform) and Accenture (business-process outsourcing) to apply AI technologies and re-engineer its core safety processes. The collaboration achieved 25% efficiency gains in PV case intake and processing, described on the page as an 'evolution journey' that optimized BMS's safety environment and workflows.
ArisGlobal makes the LifeSphere suite — safety-case management, signal detection and clinical systems used by pharmacovigilance and clinical-operations teams.
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by ArisGlobal on its own site — read the original case study on arisglobal.com ↗
Note: landing page for a gated download; full detail beyond the headline 25% figure is not on the page itself
Related use cases
- 01TCTM: Realizing Overall Business Improvements and Efficiencies with LifeSphere® CTMS
- 02Register Enables Compliance and Tracking for Post-Merger Global Pharma
- 03Multinational Medical Device and Healthcare Organization Embraces LifeSphere® LitPro to Automate Literature Search and Monitoring
- 04PPD and ArisGlobal | A Pharmacovigilance Success Story
- 05Global CRO chooses ArisGlobal to manage Clinical and Pharmacovigilance
- 06Leading Global Pharmaceutical Company selects LifeSphere Safety Document Distribution Reporting